Abstract:Dapeng Hu, 1, 2 Junwen Huang, 1 Wenqu Zhao, 1 Maosheng Xu, 1 Yanyan Ma, 1 Zhaoqian Gong, 1 Qian Zhang, 1 Haijin Zhao 1 1 Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, NanFang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China; 2 Department of Emergency Medicine, Dalian Municipal Friendship Hospital, Dalian, Liaoning, 116001, People's Republic of China Correspondence: Haijin Zhao, Chronic Airway Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China, Tel/Fax +86-2062787112, Email Purpose: Identifying prognosis for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is challenging. Eosinophils and platelet are involved in the development of COPD, which may predict adverse events. The objective of this study was to determine the effect of the eosinophil to platelet ratio (EPR) in predicting adverse events in patients with AECOPD who visited the emergency department. Patients and Methods: The records of patients with AECOPD treated at Dalian Municipal Friendship Hospital from January 2018 to December 2020 were retrospectively reviewed. The relationship between the clinical characteristics and EPR, as cut-off value of 0.755, was evaluated. Results: A total of 508 patients with an AECOPD (316 male, 192 female) were included. An optimal AUC cutoff of 0.755 for the EPR segregated the patients into 2 groups with significantly different mortality (25.3% vs 5.5%, P < 0.001). The same mortality risk with lower EPR was observed among the patients with emergency room attendance (35.6% vs 11.1%, P < 0.001). A model including EPR < 0.755, exacerbation history, PaO2 50 mm Hg, hypoalbuminemia and age ≥ 80 was developed to predict death risk and showed good performance. Conclusion: During severe COPD exacerbation, an EPR < 0.755 preceding therapy can predict worse outcomes in patients with an AECOPD. Keywords: eosinophil, COPD, eosinophil to platelet ratio, emergency department Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability worldwide. 1 Acute exacerbation of COPD (AECOPD) is commonly described as a rapid increase in COPD symptoms outside of the normal daily variation, and requires changes to daily medication. Such exacerbations are often linked to poor health status, and high rates of hospitalization, readmission, and disease progression. 2 The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in peripheral blood are being increasingly studied as systemic inflammatory markers. Notably, they can be rapidly determined, are widely available, and are relatively inexpensive through routine blood count analysis. Xiong et al 3 in a retrospective study found that baseline NLR values were significantly higher in COPD patients who died than patients who survived, indicating that the NLR might predict mortality in hospitalized COPD patients. Kumar et al 4 reported that the PLR was associated with 90-day mortality in patients with COPD. In a recent retrospective study, Yao et al 5 reported that NLR and PLR values were significantly higher in non-survivor patients with COPD, and the NLR might be a useful prognostic marker for hospital mortality in patients with an AECOPD. As such, the NLR and PLR, which are convenient and simple to calculate may be used to predict the prognosis of patients with COPD. Studies have shown that a low levels of blood eosinophils may be a predictor of a poor prognosis in patients with COPD. 6–8 In addition, an eosinophil count <50 / μL may be a useful biomarker for detecting sepsis and be a predictor of mortality in patients with a critical illness. 6 MacDonald et al 9 found that a low eosinophil count may predict higher mortality in hospitalized patients with an AECOPD. Holland et al 7 reported that a blood eosinophil count <0.04×10 9 /L was associated with higher in-hospital mortality in patients with an AECOPD. Chan et al 10 found that blood eosinophilia was associated with higher exacerbation risk in COPD patients. Prins et al 11 reported that blood eosinophilia ≥2% was associated with an increased risk of relapse. Studies have shown that a platelet count may have a role in predicting disease prognosis. Several reports found that thrombocytopenia is an independent predictor of intensive care unit (ICU) mortality, with a relative risk (RR) ran -Abstract Truncated-

Immature platelet fraction as a systemic inflammation marker in patients with chronic obstructive pulmonary disease

Relationship Between Platelet Parameters and Eosinophils with Disease Severity, CRP and Treatment in Stable COPD

Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: A comparative study

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients

Study of Inflammatory Markers in Chronic Obstructive Pulmonary Disease

A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD

Systemic Alterations in Neutrophils and Their Precursors in Early-Stage Chronic Obstructive Pulmonary Disease

Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia

Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases

CRP, Fibrinogen, White Blood Cells, and Blood Cell Indices as Prognostic Biomarkers of Future COPD Exacerbation Frequency: The TIE Cohort Study

Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease

The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease

Alterations of Plasma Inflammatory Biomarkers in the Healthy and Chronic Obstructive Pulmonary Disease Patients with or Without Acute Exacerbation.

Relationship Between Platelet Activation and Chronic Obstructive Pulmonary Disease.

Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease

Using Inflammatory Index to Distinguish Asthma, Asthma-Copd Overlap and COPD: A Retrospective Observational Study.